Annals of Internal Medicine· 2012Q1· Guideline
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
- 1,092citations
- Q1SCImago
- 2012year
Short summary
AABB recommends a restrictive red blood cell (RBC) transfusion strategy (7-8 g/dL hemoglobin) for stable hospitalized adults and children, supported by high-quality evidence.
AI-generated from the title and abstract; the full text is not read.
Key points
- Recommends a restrictive transfusion strategy (7-8 g/dL hemoglobin) for stable hospitalized patients (strong recommendation, high-quality evidence).
- Suggests a restrictive strategy for hospitalized patients with pre-existing cardiovascular disease, considering transfusion for symptomatic patients or those with hemoglobin ≤ 8 g/dL (weak recommendation, moderate-quality evidence).
- Cannot recommend for or against liberal vs. restrictive thresholds for stable acute coronary syndrome patients (uncertain recommendation, very low-quality evidence).
- Suggests that symptoms, in addition to hemoglobin concentration, should influence transfusion decisions (weak recommendation, low-quality evidence).
AI-generated from the title and abstract; the full text is not read.
Abstract
DESCRIPTION: Although approximately 85 million units of red blood cells (RBCs) are transfused annually worldwide, transfusion practices vary widely. The AABB (formerly, the American Association of Blood Banks) developed this guideline to provide clinical recommendations about hemoglobin concentration thresholds and other clinical variables that trigger RBC transfusions in hemodynamically stable adults and children. METHODS: These guidelines are based on a systematic review of randomized clinical trials evaluating transfusion thresholds. We performed a literature search from 1950 to February 2011 with no language restrictions. We examined the proportion of patients who received any RBC transfusion and the number of RBC units transfused to describe the effect of restrictive transfusion strategies on RBC use. To determine the clinical consequences of restrictive transfusion strategies, we examined overall mortality, nonfatal myocardial infarction, cardiac events, pulmonary edema, stroke, thromboembolism, renal failure, infection, hemorrhage, mental confusion, functional recovery, and length of hospital stay. RECOMMENDATION 1: The AABB recommends adhering to a restrictive transfusion strategy (7 to 8 g/dL) in hospitalized, stable patients (Grade: strong recommendation; high-quality evidence). RECOMMENDATION 2: The AABB suggests adhering to a restrictive strategy in hospitalized patients with preexisting cardiovascular disease and considering transfusion for patients with symptoms or a hemoglobin level of 8 g/dL or less (Grade: weak recommendation; moderate-quality evidence). RECOMMENDATION 3: The AABB cannot recommend for or against a liberal or restrictive transfusion threshold for hospitalized, hemodynamically stable patients with the acute coronary syndrome (Grade: uncertain recommendation; very low-quality evidence). RECOMMENDATION 4: The AABB suggests that transfusion decisions be influenced by symptoms as well as hemoglobin concentration (Grade: weak recommendation; low-quality evidence).
The authors' abstract, as published at the source. Annals of Internal Medicine, 2012 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Biochemistry (Medicine)
BiochemistryMedicine